Cinchocaine en es it fr

Cinchocaine Brand names, Cinchocaine Analogs

Cinchocaine Brand Names Mixture

  • No information avaliable

Cinchocaine Chemical_Formula

C21H27NO

Cinchocaine RX_link

No information avaliable

Cinchocaine fda sheet

Cinchocaine FDA

Cinchocaine msds (material safety sheet)

Cinchocaine MSDS

Cinchocaine Synthesis Reference

No information avaliable

Cinchocaine Molecular Weight

309.445 g/mol

Cinchocaine Melting Point

No information avaliable

Cinchocaine H2O Solubility

No information avaliable

Cinchocaine State

Solid

Cinchocaine LogP

4.86

Cinchocaine Dosage Forms

Tablets for oral administration (25 mg, 50 mg)

Cinchocaine Indication

For use in the prevention and symptomatic treatment of peripheral (labyrinthine) vertigo and associated nausea and vomiting that occur in such conditions as Meniere's disease and surgery of the middle and inner ear. Also for the control of nausea and vomiting associated with postoperative states, malignant neoplasms, labyrinthine disturbances, antineoplastic agent therapy, radiation sickness, and infectious diseases.

Cinchocaine Pharmacology

No information avaliable

Cinchocaine Absorption

Well absorbed from gastrointestinal tract following oral administration.

Cinchocaine side effects and Toxicity

Symptoms of overdose include drowsiness (severe); shortness of breath or troubled breathing; unusual tiredness or weakness (severe).

Cinchocaine Patient Information

No information avaliable

Cinchocaine Organisms Affected

Humans and other mammals